Ignite Creation Date:
2024-10-26 @ 3:43 PM
Last Modification Date:
2024-10-26 @ 3:43 PM
Study NCT ID:
NCT06656832
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-10-22
Brief Title:
Peripheral Drivers of Heart Failure Progression - the Prospective PEDAL-HF Study
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Peripheral Drivers of Heart Failure Progression - the Prospective PEDAL-HF Study
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
PEDAL-HF
Brief Summary:
PEDAL-HF is a registry-based randomized prospective multicenter study We plan to include 1000 patients who were recently admitted with acute decompensated heart failure at five tertiary heart clinics in Germany For the randomised part 750 patients will be randomized to care within a heart failure network or usual care The primary endpoint of the randomized trial is change in NT-proBNP from baseline to 6 months of follow-up
All patients randomized or not will be followed for two years
All patients randomized or not will be followed for two years
Detailed Description:
See above
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None